Virtu Financial’s NovaBay Pharmaceuticals NBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-27,719
| Closed | -$17K | – | 1800 |
|
|
2024
Q4 | $17K | Buy |
27,719
+8,129
| +41% | +$4.99K | ﹤0.01% | 1322 |
|
|
2024
Q3 | $13K | Buy |
+19,590
| New | +$13K | ﹤0.01% | 1170 |
|
|
2024
Q1 | – | Sell |
-1,852
| Closed | -$13K | – | 1855 |
|
|
2023
Q4 | $13K | Buy |
+1,852
| New | +$13K | ﹤0.01% | 1384 |
|
|
2022
Q3 | – | Sell |
-13
| Closed | -$4K | – | 2042 |
|
|
2022
Q2 | $4K | Sell |
13
-120
| -90% | -$36.9K | ﹤0.01% | 1474 |
|
|
2022
Q1 | $48K | Buy |
133
+96
| +259% | +$34.6K | ﹤0.01% | 1147 |
|
|
2021
Q4 | $17K | Sell |
37
-72
| -66% | -$33.1K | ﹤0.01% | 1531 |
|
|
2021
Q3 | $86K | Buy |
109
+99
| +990% | +$78.1K | 0.01% | 1185 |
|
|
2021
Q2 | $9K | Sell |
10
-16
| -62% | -$14.4K | ﹤0.01% | 1427 |
|
|
2021
Q1 | $29K | Sell |
26
-17
| -40% | -$19K | ﹤0.01% | 1483 |
|
|
2020
Q4 | $36K | Buy |
43
+5
| +13% | +$4.19K | ﹤0.01% | 1285 |
|
|
2020
Q3 | $34K | Buy |
+38
| New | +$34K | 0.01% | 863 |
|
|
2019
Q4 | $46K | Buy |
58
+32
| +123% | +$25.4K | ﹤0.01% | 1215 |
|
|
2019
Q3 | $19K | Sell |
26
-44
| -63% | -$32.2K | ﹤0.01% | 1295 |
|
|
2019
Q2 | $145K | Buy |
+70
| New | +$145K | 0.01% | 1059 |
|